A Novel 5-HT1B Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer's Disease

• Main Authors: Yang Yang (Author), Lijing Zhang (Author), Jiaojiao Yu (Author), Zhaobin Ma (Author), Moxiang Li (Author), Jin Wang (Author), Pengcheng Hu (Author), Jia Zou (Author), Xueying Liu (Author), Ying Liu (Author), Su An (Author), Cheng Xiang (Author), Xiaoxi Guo (Author), Qian Hao (Author), Tian-Rui Xu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The serotonin receptor 5-HT1B is widely expressed in the central nervous system and has been considered a drug target in a variety of cognitive and psychiatric disorders. The anti-inflammatory effects of 5-HT1B agonists may present a promising approach for Alzheimer's disease (AD) treatment. He...